Xril DM Syrup is a combination pharmaceutical formulation containing Chlorpheniramine Maleate (2mg/5ml) and Dextromethorphan Hydrobromide (10mg/5ml), indicated for the symptomatic relief of cough and allergic conditions associated with upper respiratory tract infections. Chlorpheniramine Maleate, an antihistamine, exerts its effect by competitively inhibiting histamine H1 receptors, thereby reducing allergic manifestations such as rhinorrhea, sneezing, and nasal congestion. Dextromethorphan Hydrobromide acts centrally on the cough center in the medulla oblongata to suppress the cough reflex, providing effective relief from dry, non-productive cough. Xril DM Syrup is suitable for use in adults and children above the recommended age, with dosage adjusted accordingly. It is important to adhere to prescribed dosing to minimize potential side effects, which may include drowsiness, dizziness, dry mouth, and gastrointestinal disturbances. Caution is advised in patients with a history of hypersensitivity to any component, respiratory depression, or concurrent use of monoamine oxidase inhibitors (MAOIs). This formulation should be used under medical supervision, especially in individuals with chronic respiratory diseases, liver or kidney impairment, or other significant comorbidities. Xril DM Syrup offers a dual-action approach to managing cough and allergy symptoms, improving patient comfort and facilitating recovery.